Sos1 deficiency ameliorates oncogenic KRAS-mediated hematopoietic stem cell exhaustion and myeloid progenitor expansion
Constitutive KRAS activating mutations are prevalent in hematopoietic malignancies. Our previous study showed that the deficiency of Sos1 prolongs the survival of KrasG12D/+ mice. However, whether Sos1 deletion ameliorates oncogenic Kras-mediated hematopoietic defects remains unknown. Here, we found...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | Pharmaceutical Science Advances |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2773216924000199 |